 | • レポートコード：MRC2-11QY12229 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は医療関連感染（HAI）治療のグローバル市場について調査・分析したレポートです。種類別（尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、耳鼻咽喉科感染症、皮膚感染症、骨感染症）市場規模、用途別（病院薬局、小売薬局、ドラッグストア、Eコマース）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別医療関連感染（HAI）治療の競争状況、市場シェア ・世界の医療関連感染（HAI）治療市場：種類別市場規模 2015年-2020年（尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、耳鼻咽喉科感染症、皮膚感染症、骨感染症） ・世界の医療関連感染（HAI）治療市場：種類別市場規模予測 2021年-2026年（尿路感染症、換気装置関連肺炎、手術部位感染症、血流感染症、胃腸感染症、耳鼻咽喉科感染症、皮膚感染症、骨感染症） ・世界の医療関連感染（HAI）治療市場：用途別市場規模 2015年-2020年（病院薬局、小売薬局、ドラッグストア、Eコマース） ・世界の医療関連感染（HAI）治療市場：用途別市場規模予測 2021年-2026年（病院薬局、小売薬局、ドラッグストア、Eコマース） ・北米の医療関連感染（HAI）治療市場分析：米国、カナダ ・ヨーロッパの医療関連感染（HAI）治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの医療関連感染（HAI）治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の医療関連感染（HAI）治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの医療関連感染（HAI）治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Pfizer、Bayer、Cepheid、AstraZeneca、Roche、Johnson & Johnson、Merck、Cipla、GlaxoSmithKline、Aridis Pharmaceuticals、Astellas Pharma、Daiichi Sankyo、Bristol-Myers Squibb、Eli Lilly ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Hospital Acquired Infection Treatment is an infection that is acquired in a hospital or other health care facility.
Market Analysis and Insights: Global Hospital Acquired Infection Treatment Market
The global Hospital Acquired Infection Treatment market size is projected to reach US$ 19430 million by 2026, from US$ 19090 million in 2020, at a CAGR of 1.6%% during 2021-2026.
Global Hospital Acquired Infection Treatment Scope and Market Size
Hospital Acquired Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Pfizer
Bayer
Cepheid
AstraZeneca
Roche
Johnson & Johnson
Merck
Cipla
GlaxoSmithKline
Aridis Pharmaceuticals
Astellas Pharma
Daiichi Sankyo
Bristol-Myers Squibb
Eli Lilly
Market segment by Type, the product can be split into
Urinary Tract Infections
Ventilator Associated Pneumonia
Surgical Site Infections
Bloodstream Infections
Gastrointestinal Infection
ENT Infections
Skin Infection
Bone Infection
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Drug Store
E-Commerce
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hospital Acquired Infection Treatment Revenue
1.4 Market by Type
1.4.1 Global Hospital Acquired Infection Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Urinary Tract Infections
1.4.3 Ventilator Associated Pneumonia
1.4.4 Surgical Site Infections
1.4.5 Bloodstream Infections
1.4.6 Gastrointestinal Infection
1.4.7 ENT Infections
1.4.8 Skin Infection
1.4.9 Bone Infection
1.5 Market by Application
1.5.1 Global Hospital Acquired Infection Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Drug Store
1.5.5 E-Commerce
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hospital Acquired Infection Treatment Market Perspective (2015-2026)
2.2 Global Hospital Acquired Infection Treatment Growth Trends by Regions
2.2.1 Hospital Acquired Infection Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hospital Acquired Infection Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Hospital Acquired Infection Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hospital Acquired Infection Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Hospital Acquired Infection Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hospital Acquired Infection Treatment Players by Market Size
3.1.1 Global Top Hospital Acquired Infection Treatment Players by Revenue (2015-2020)
3.1.2 Global Hospital Acquired Infection Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Hospital Acquired Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hospital Acquired Infection Treatment Market Concentration Ratio
3.2.1 Global Hospital Acquired Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hospital Acquired Infection Treatment Revenue in 2019
3.3 Hospital Acquired Infection Treatment Key Players Head office and Area Served
3.4 Key Players Hospital Acquired Infection Treatment Product Solution and Service
3.5 Date of Enter into Hospital Acquired Infection Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hospital Acquired Infection Treatment Historic Market Size by Type (2015-2020)
4.2 Global Hospital Acquired Infection Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
5.2 Global Hospital Acquired Infection Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hospital Acquired Infection Treatment Market Size (2015-2020)
6.2 Hospital Acquired Infection Treatment Key Players in North America (2019-2020)
6.3 North America Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
6.4 North America Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hospital Acquired Infection Treatment Market Size (2015-2020)
7.2 Hospital Acquired Infection Treatment Key Players in Europe (2019-2020)
7.3 Europe Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
7.4 Europe Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
8 China
8.1 China Hospital Acquired Infection Treatment Market Size (2015-2020)
8.2 Hospital Acquired Infection Treatment Key Players in China (2019-2020)
8.3 China Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
8.4 China Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hospital Acquired Infection Treatment Market Size (2015-2020)
9.2 Hospital Acquired Infection Treatment Key Players in Japan (2019-2020)
9.3 Japan Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
9.4 Japan Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hospital Acquired Infection Treatment Market Size (2015-2020)
10.2 Hospital Acquired Infection Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
11 India
11.1 India Hospital Acquired Infection Treatment Market Size (2015-2020)
11.2 Hospital Acquired Infection Treatment Key Players in India (2019-2020)
11.3 India Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
11.4 India Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hospital Acquired Infection Treatment Market Size (2015-2020)
12.2 Hospital Acquired Infection Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Hospital Acquired Infection Treatment Market Size by Type (2015-2020)
12.4 Central & South America Hospital Acquired Infection Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Hospital Acquired Infection Treatment Introduction
13.1.4 Abbott Revenue in Hospital Acquired Infection Treatment Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Hospital Acquired Infection Treatment Introduction
13.2.4 Pfizer Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Hospital Acquired Infection Treatment Introduction
13.3.4 Bayer Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Cepheid
13.4.1 Cepheid Company Details
13.4.2 Cepheid Business Overview
13.4.3 Cepheid Hospital Acquired Infection Treatment Introduction
13.4.4 Cepheid Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.4.5 Cepheid Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Hospital Acquired Infection Treatment Introduction
13.5.4 AstraZeneca Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.5.5 AstraZeneca Recent Development
13.6 Roche
13.6.1 Roche Company Details
13.6.2 Roche Business Overview
13.6.3 Roche Hospital Acquired Infection Treatment Introduction
13.6.4 Roche Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.6.5 Roche Recent Development
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Details
13.7.2 Johnson & Johnson Business Overview
13.7.3 Johnson & Johnson Hospital Acquired Infection Treatment Introduction
13.7.4 Johnson & Johnson Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.7.5 Johnson & Johnson Recent Development
13.8 Merck
13.8.1 Merck Company Details
13.8.2 Merck Business Overview
13.8.3 Merck Hospital Acquired Infection Treatment Introduction
13.8.4 Merck Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.8.5 Merck Recent Development
13.9 Cipla
13.9.1 Cipla Company Details
13.9.2 Cipla Business Overview
13.9.3 Cipla Hospital Acquired Infection Treatment Introduction
13.9.4 Cipla Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.9.5 Cipla Recent Development
13.10 GlaxoSmithKline
13.10.1 GlaxoSmithKline Company Details
13.10.2 GlaxoSmithKline Business Overview
13.10.3 GlaxoSmithKline Hospital Acquired Infection Treatment Introduction
13.10.4 GlaxoSmithKline Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
13.10.5 GlaxoSmithKline Recent Development
13.11 Aridis Pharmaceuticals
10.11.1 Aridis Pharmaceuticals Company Details
10.11.2 Aridis Pharmaceuticals Business Overview
10.11.3 Aridis Pharmaceuticals Hospital Acquired Infection Treatment Introduction
10.11.4 Aridis Pharmaceuticals Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
10.11.5 Aridis Pharmaceuticals Recent Development
13.12 Astellas Pharma
10.12.1 Astellas Pharma Company Details
10.12.2 Astellas Pharma Business Overview
10.12.3 Astellas Pharma Hospital Acquired Infection Treatment Introduction
10.12.4 Astellas Pharma Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
10.12.5 Astellas Pharma Recent Development
13.13 Daiichi Sankyo
10.13.1 Daiichi Sankyo Company Details
10.13.2 Daiichi Sankyo Business Overview
10.13.3 Daiichi Sankyo Hospital Acquired Infection Treatment Introduction
10.13.4 Daiichi Sankyo Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
10.13.5 Daiichi Sankyo Recent Development
13.14 Bristol-Myers Squibb
10.14.1 Bristol-Myers Squibb Company Details
10.14.2 Bristol-Myers Squibb Business Overview
10.14.3 Bristol-Myers Squibb Hospital Acquired Infection Treatment Introduction
10.14.4 Bristol-Myers Squibb Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
10.14.5 Bristol-Myers Squibb Recent Development
13.15 Eli Lilly
10.15.1 Eli Lilly Company Details
10.15.2 Eli Lilly Business Overview
10.15.3 Eli Lilly Hospital Acquired Infection Treatment Introduction
10.15.4 Eli Lilly Revenue in Hospital Acquired Infection Treatment Business (2015-2020)
10.15.5 Eli Lilly Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hospital Acquired Infection Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Hospital Acquired Infection Treatment Revenue
Table 3. Ranking of Global Top Hospital Acquired Infection Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hospital Acquired Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Urinary Tract Infections
Table 6. Key Players of Ventilator Associated Pneumonia
Table 7. Key Players of Surgical Site Infections
Table 8. Key Players of Bloodstream Infections
Table 9. Key Players of Gastrointestinal Infection
Table 10. Key Players of ENT Infections
Table 11. Key Players of Skin Infection
Table 12. Key Players of Bone Infection
Table 13. Global Hospital Acquired Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Hospital Acquired Infection Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Hospital Acquired Infection Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Hospital Acquired Infection Treatment Market Share by Regions (2015-2020)
Table 17. Global Hospital Acquired Infection Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Hospital Acquired Infection Treatment Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Hospital Acquired Infection Treatment Market Growth Strategy
Table 23. Main Points Interviewed from Key Hospital Acquired Infection Treatment Players
Table 24. Global Hospital Acquired Infection Treatment Revenue by Players (2015-2020) (Million US$)
Table 25. Global Hospital Acquired Infection Treatment Market Share by Players (2015-2020)
Table 26. Global Top Hospital Acquired Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infection Treatment as of 2019)
Table 27. Global Hospital Acquired Infection Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Hospital Acquired Infection Treatment Product Solution and Service
Table 30. Date of Enter into Hospital Acquired Infection Treatment Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 33. Global Hospital Acquired Infection Treatment Market Size Share by Type (2015-2020)
Table 34. Global Hospital Acquired Infection Treatment Revenue Market Share by Type (2021-2026)
Table 35. Global Hospital Acquired Infection Treatment Market Size Share by Application (2015-2020)
Table 36. Global Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. Global Hospital Acquired Infection Treatment Market Size Share by Application (2021-2026)
Table 38. North America Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 40. North America Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. North America Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 42. North America Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. North America Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 44. Europe Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 46. Europe Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 48. Europe Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 50. China Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 51. China Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 52. China Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. China Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 54. China Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. China Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 56. Japan Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 58. Japan Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 60. Japan Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 64. Southeast Asia Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 66. Southeast Asia Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 68. India Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 69. India Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 70. India Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. India Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 72. India Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. India Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Hospital Acquired Infection Treatment Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Hospital Acquired Infection Treatment Market Share (2019-2020)
Table 76. Central & South America Hospital Acquired Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Hospital Acquired Infection Treatment Market Share by Type (2015-2020)
Table 78. Central & South America Hospital Acquired Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Hospital Acquired Infection Treatment Market Share by Application (2015-2020)
Table 80. Abbott Company Details
Table 81. Abbott Business Overview
Table 82. Abbott Product
Table 83. Abbott Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 84. Abbott Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Product
Table 93. Bayer Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 94. Bayer Recent Development
Table 95. Cepheid Company Details
Table 96. Cepheid Business Overview
Table 97. Cepheid Product
Table 98. Cepheid Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 99. Cepheid Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Product
Table 103. AstraZeneca Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 104. AstraZeneca Recent Development
Table 105. Roche Company Details
Table 106. Roche Business Overview
Table 107. Roche Product
Table 108. Roche Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 109. Roche Recent Development
Table 110. Johnson & Johnson Company Details
Table 111. Johnson & Johnson Business Overview
Table 112. Johnson & Johnson Product
Table 113. Johnson & Johnson Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 114. Johnson & Johnson Recent Development
Table 115. Merck Business Overview
Table 116. Merck Product
Table 117. Merck Company Details
Table 118. Merck Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 119. Merck Recent Development
Table 120. Cipla Company Details
Table 121. Cipla Business Overview
Table 122. Cipla Product
Table 123. Cipla Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 124. Cipla Recent Development
Table 125. GlaxoSmithKline Company Details
Table 126. GlaxoSmithKline Business Overview
Table 127. GlaxoSmithKline Product
Table 128. GlaxoSmithKline Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 129. GlaxoSmithKline Recent Development
Table 130. Aridis Pharmaceuticals Company Details
Table 131. Aridis Pharmaceuticals Business Overview
Table 132. Aridis Pharmaceuticals Product
Table 133. Aridis Pharmaceuticals Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 134. Aridis Pharmaceuticals Recent Development
Table 135. Astellas Pharma Company Details
Table 136. Astellas Pharma Business Overview
Table 137. Astellas Pharma Product
Table 138. Astellas Pharma Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 139. Astellas Pharma Recent Development
Table 140. Daiichi Sankyo Company Details
Table 141. Daiichi Sankyo Business Overview
Table 142. Daiichi Sankyo Product
Table 143. Daiichi Sankyo Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 144. Daiichi Sankyo Recent Development
Table 145. Bristol-Myers Squibb Company Details
Table 146. Bristol-Myers Squibb Business Overview
Table 147. Bristol-Myers Squibb Product
Table 148. Bristol-Myers Squibb Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 149. Bristol-Myers Squibb Recent Development
Table 150. Eli Lilly Company Details
Table 151. Eli Lilly Business Overview
Table 152. Eli Lilly Product
Table 153. Eli Lilly Revenue in Hospital Acquired Infection Treatment Business (2015-2020) (Million US$)
Table 154. Eli Lilly Recent Development
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital Acquired Infection Treatment Market Share by Type: 2020 VS 2026
Figure 2. Urinary Tract Infections Features
Figure 3. Ventilator Associated Pneumonia Features
Figure 4. Surgical Site Infections Features
Figure 5. Bloodstream Infections Features
Figure 6. Gastrointestinal Infection Features
Figure 7. ENT Infections Features
Figure 8. Skin Infection Features
Figure 9. Bone Infection Features
Figure 10. Global Hospital Acquired Infection Treatment Market Share by Application: 2020 VS 2026
Figure 11. Hospital Pharmacies Case Studies
Figure 12. Retail Pharmacies Case Studies
Figure 13. Drug Store Case Studies
Figure 14. E-Commerce Case Studies
Figure 15. Hospital Acquired Infection Treatment Report Years Considered
Figure 16. Global Hospital Acquired Infection Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Hospital Acquired Infection Treatment Market Share by Regions: 2020 VS 2026
Figure 18. Global Hospital Acquired Infection Treatment Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Hospital Acquired Infection Treatment Market Share by Players in 2019
Figure 21. Global Top Hospital Acquired Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hospital Acquired Infection Treatment as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Hospital Acquired Infection Treatment Revenue in 2019
Figure 23. North America Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Hospital Acquired Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Bottom-up and Top-down Approaches for This Report
Figure 31. Data Triangulation
Figure 32. Key Executives Interviewed
医療関連感染（HAI）管理の世界市場（～2026年） A hospital-acquired infection (HAI), also known as a nosocomial infection, is an infection that is acquired in a hospital or other health care facility. The rise in the incidences of different types of hospital acquired infections, innovative technologies implemented in devices that control infectio…- 尿路感染症治療の世界市場（～2026年） Urinary tract infection (UTI) is a common infections of the urinary tract, which consists of the kidneys, ureters, bladder, urethra or prostate gland. This trend of increment in the prevalence rate of diabetes among adults is expected to continue during the forecast period. Therefore, with increasin…
- 医療関連感染（HAI）診断の世界市場（～2026年） Patients may catch infections during they are in the hospital, the hospital acquired infection test is used to diagnose those infections. The industry is anticipated to witness a significant growth in the next few years. One of the key factors driving industry growth is the rising geriatric populati…
- 院内感染治療の世界市場（～2026年） Hospital-acquired infections, also known as nosocomial infections, are acquired by patients in the hospitals or healthcare facilities. Urinary tract infections, bloodstream infections, surgical-site infections, Clostridium difficile associated diarrhea, and pneumonia are examples of nosocomial infec…
- 下気道感染症治療の世界市場（～2026年） The infection below the level of larynx is said to be lower respiratory tract infection. Many a times, lower respiratory tract infection is called pneumonia. These infection are not defined uniformly, but epidemiologically, these infections includes flu, bronchitis, bronchiolitis, and pneumonia. The…